Related references
Note: Only part of the references are listed.Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010-2017
Ashley H. Hirai et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Neonatal Abstinence Syndrome Incidence and Health Care Costs in the United States, 2016
Andrea E. Strahan et al.
JAMA PEDIATRICS (2020)
Neonatal Abstinence Syndrome
Lauren M. Jansson et al.
PEDIATRIC CLINICS OF NORTH AMERICA (2019)
Neonatal abstinence syndrome
Mara G. Coyle et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Increased DNA Methylation of ABCB1, CYP2D6, and OPRM1 Genes in Newborn Infants of Methadone-Maintained Opioid-Dependent Mothers
Poppy McLaughlin et al.
JOURNAL OF PEDIATRICS (2017)
Early Prediction Tool to Identify the Need for Pharmacotherapy in Infants at Risk of Neonatal Abstinence Syndrome
Barbara T. Isemann et al.
PHARMACOTHERAPY (2017)
Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012 (vol 35, pg 667, 2015)
S. W. Patrick et al.
JOURNAL OF PERINATOLOGY (2015)
Increasing Incidence of the Neonatal Abstinence Syndrome in US Neonatal ICUs
Veeral N. Tolia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Epigenetic Variation in the Mu-Opioid Receptor Gene in Infants with Neonatal Abstinence Syndrome
Elisha M. Wachman et al.
JOURNAL OF PEDIATRICS (2014)
Effectiveness of a Clinical Pathway With Methadone Treatment Protocol for Treatment of Neonatal Abstinence Syndrome Following In Utero Drug Exposure to Substances of Abuse
Varsha Bhatt-Mehta et al.
PEDIATRIC CRITICAL CARE MEDICINE (2014)
The relationship between maternal methadone dose at delivery and neonatal outcome: Methodological and design considerations
Hendree E. Jones et al.
NEUROTOXICOLOGY AND TERATOLOGY (2013)
Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication
Karol Kaltenbach et al.
ADDICTION (2012)
Maternal Methadone Dose, Placental Methadone Concentrations, and Neonatal Outcomes
Ana de Castro et al.
CLINICAL CHEMISTRY (2011)
Methadone, Cocaine, Opiates, and Metabolite Disposition in Umbilical Cord and Correlations to Maternal Methadone Dose and Neonatal Outcomes
Ana de Castro et al.
THERAPEUTIC DRUG MONITORING (2011)
Relationship between Maternal Methadone Dose at Delivery and Neonatal Abstinence Syndrome
Neil S. Seligman et al.
JOURNAL OF PEDIATRICS (2010)
Maternal methadone dose during pregnancy and infant clinical outcome
Trecia A. Wouldes et al.
NEUROTOXICOLOGY AND TERATOLOGY (2010)
Drug transporters in the human blood-placental barrier
Kirsi Vahakangas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Methadone metabolism by early gestational age placentas
Todd Lewis Hieronymus et al.
AMERICAN JOURNAL OF PERINATOLOGY (2006)
Determination of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and alprazolam in human plasma by liquid chromatography-electrospray ionization mass spectrometry
O Quintela et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2006)
Role of P-glycoprotein in transplacental transfer of methadone
T Nanovskaya et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Can methadone concentrations predict the severity of withdrawal in infants at risk of neonatal abstinence syndrome?
CA Kuschel et al.
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2004)
The effects of methadone and its role in fatalities
JM Corkery et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2004)
Maternal methadone dose and neonatal withdrawal
V Berghella et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)